A carregar...

Cardiovascular benefits of SGLT2 inhibitors in patients with heart failure: a meta-analysis of small and large randomized controlled trials

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in improving cardiovascular outcome in patients with heart failure (HF) and diabetes mellitus (DM). Although these benefits have been confirmed by several meta-analyses, small studies have not been included into these p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cardiovasc Dis
Main Authors: Shoar, Saeed, Shah, Ahmed Ali, Ikram, Waleed, Farooq, Najam, Udoh, Agnes, Tabibzadeh, Elsa, Khavandi, Soheila, Khavandi, Siamak
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303041/
https://ncbi.nlm.nih.gov/pubmed/34322297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!